keyword
https://read.qxmd.com/read/38646965/accuracy-and-usability-of-artificial-intelligence-chatbot-generated-chemotherapy-protocols
#1
JOURNAL ARTICLE
Efe Cem Erdat, Merih Yalciner, Yuksel Urun
Background: Medical practitioners are increasingly using artificial intelligence (AI) chatbots for easier and faster access to information. To our knowledge, the accuracy and availability of AI-generated chemotherapy protocols has not yet been studied. Methods: Nine simulated cancer patient cases were designed and AI chatbots, ChatGPT version 3.5 (OpenAI) and Bing (Microsoft), were used to generate chemotherapy protocols for each case. Results: Generated chemotherapy protocols were compared with the original protocols for nine simulated cancer patients...
April 22, 2024: Future Oncology
https://read.qxmd.com/read/38646416/artificial-neural-network-assisted-prediction-of-radiobiological-indices-in-head-and-neck-cancer
#2
JOURNAL ARTICLE
Saad Bin Saeed Ahmed, Shahzaib Naeem, Agha Muhammad Hammad Khan, Bilal Mazhar Qureshi, Amjad Hussain, Bulent Aydogan, Wazir Muhammad
BACKGROUND AND PURPOSE: We proposed an artificial neural network model to predict radiobiological parameters for the head and neck squamous cell carcinoma patients treated with radiation therapy. The model uses the tumor specification, demographics, and radiation dose distribution to predict the tumor control probability and the normal tissue complications probability. These indices are crucial for the assessment and clinical management of cancer patients during treatment planning. METHODS: Two publicly available datasets of 31 and 215 head and neck squamous cell carcinoma patients treated with conformal radiation therapy were selected...
2024: Frontiers in artificial intelligence
https://read.qxmd.com/read/38646415/application-of-machine-learning-for-lung-cancer-survival-prognostication-a-systematic-review-and-meta-analysis
#3
Alexander J Didier, Anthony Nigro, Zaid Noori, Mohamed A Omballi, Scott M Pappada, Danae M Hamouda
INTRODUCTION: Machine learning (ML) techniques have gained increasing attention in the field of healthcare, including predicting outcomes in patients with lung cancer. ML has the potential to enhance prognostication in lung cancer patients and improve clinical decision-making. In this systematic review and meta-analysis, we aimed to evaluate the performance of ML models compared to logistic regression (LR) models in predicting overall survival in patients with lung cancer. METHODS: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement...
2024: Frontiers in artificial intelligence
https://read.qxmd.com/read/38646386/advancements-in-pancreatic-cancer-detection-integrating-biomarkers-imaging-technologies-and-machine-learning-for-early-diagnosis
#4
REVIEW
Hisham Daher, Sneha A Punchayil, Amro Ahmed Elbeltagi Ismail, Reuben Ryan Fernandes, Joel Jacob, Mohab H Algazzar, Mohammad Mansour
Artificial intelligence (AI) has come to play a pivotal role in revolutionizing medical practices, particularly in the field of pancreatic cancer detection and management. As a leading cause of cancer-related deaths, pancreatic cancer warrants innovative approaches due to its typically advanced stage at diagnosis and dismal survival rates. Present detection methods, constrained by limitations in accuracy and efficiency, underscore the necessity for novel solutions. AI-driven methodologies present promising avenues for enhancing early detection and prognosis forecasting...
March 2024: Curēus
https://read.qxmd.com/read/38646364/screening-of-oral-squamous-cell-carcinoma-through-color-intensity-based-textural-features
#5
JOURNAL ARTICLE
Preethi N Sharma, Minal Chaudhary, Shraddha A Patel, Prajakta R Zade
Background Early screening and diagnosis of oral squamous cell carcinoma (OSCC) has always been a major challenge for pathologists. Artificial intelligence (AI)-assisted screening tools can serve as an adjunct for the objective interpretation of Papanicolaou (PAP)-stained oral smears. Aim This study aimed to develop a handy and sensitive computer-assisted AI tool based on color-intensity textural features to be applied to cytologic images for screening and diagnosis of OSCC. Methodology The study included two groups consisting of 80 OSCC subjects and 80 control groups...
March 2024: Curēus
https://read.qxmd.com/read/38645446/application-value-of-the-automated-machine-learning-model-based-on-modified-ct-index-combined-with-serological-indices-in-the-early-prediction-of-lung-cancer
#6
JOURNAL ARTICLE
Leyuan Meng, Ping Zhu, Kaijian Xia
BACKGROUND AND OBJECTIVE: Accurately predicting the extent of lung tumor infiltration is crucial for improving patient survival and cure rates. This study aims to evaluate the application value of an improved CT index combined with serum biomarkers, obtained through an artificial intelligence recognition system analyzing CT features of pulmonary nodules, in early prediction of lung cancer infiltration using machine learning models. PATIENTS AND METHODS: A retrospective analysis was conducted on clinical data of 803 patients hospitalized for lung cancer treatment from January 2020 to December 2023 at two hospitals: Hospital 1 (Affiliated Changshu Hospital of Soochow University) and Hospital 2 (Nantong Eighth People's Hospital)...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38644280/-exploration-and-practice-of-cardio-oncology
#7
JOURNAL ARTICLE
Y Liu, X X Zhang, F Q Fang, Y L Xia
With the improvement of oncology diagnosis and treatment, the survival time of cancer patients has been significantly prolonged, and the cancer therapy-related cardiovascular toxicity such as radiotherapy, chemotherapy, immunotherapy, and surgery are becoming more and more prominent, and it is in this context that the germ of Cardio-Oncology exploration has come into being. The multidisciplinary Cardio-Oncology team aims to establish a multidisciplinary prevention and control system to assess patients' baseline risk factors, individualized monitoring, and weighing the risk-benefit ratio of cancer therapy...
April 23, 2024: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/38644241/-endoscopic-response-evaluation-in-gastrointestinal-cancers-after-neoadjuvant-chemora-diotherapy
#8
JOURNAL ARTICLE
S J Li, J Wang, Q Wu
Neoadjuvant chemoradiotherapy has emerged as the standard treatment for locally advanced rectal cancer, esophageal cancer and gastroesophageal junction cancer which can not only improve the rate of local control but also induce pathological complete response in some patients. For patients who have achieved clinical complete response after neoadjuvant therapy, the watch & wait strategy and organ preservation could reduce unnecessary surgery and minimize the risk of postoperative complications, meanwhile greatly improve patients' quality of life without affecting the oncologic outcome...
April 25, 2024: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38643291/fastmri-prostate-a-public-biparametric-mri-dataset-to-advance-machine-learning-for-prostate-cancer-imaging
#9
JOURNAL ARTICLE
Radhika Tibrewala, Tarun Dutt, Angela Tong, Luke Ginocchio, Riccardo Lattanzi, Mahesh B Keerthivasan, Steven H Baete, Sumit Chopra, Yvonne W Lui, Daniel K Sodickson, Hersh Chandarana, Patricia M Johnson
Magnetic resonance imaging (MRI) has experienced remarkable advancements in the integration of artificial intelligence (AI) for image acquisition and reconstruction. The availability of raw k-space data is crucial for training AI models in such tasks, but public MRI datasets are mostly restricted to DICOM images only. To address this limitation, the fastMRI initiative released brain and knee k-space datasets, which have since seen vigorous use. In May 2023, fastMRI was expanded to include biparametric (T2- and diffusion-weighted) prostate MRI data from a clinical population...
April 20, 2024: Scientific Data
https://read.qxmd.com/read/38642702/a-new-era-of-antibody-discovery-an-in-depth-review-of-ai-driven-approaches
#10
REVIEW
Jin Cheng, Tianjian Liang, Xiang-Qun Xie, Zhiwei Feng, Li Meng
Given their high affinity and specificity for a range of macromolecules, antibodies are widely used in the treatment of autoimmune diseases, cancers, inflammatory diseases, and Alzheimer's disease (AD). Traditional experimental methods are time-consuming, expensive, and labor-intensive. Recent advances in artificial intelligence (AI) technologies provide complementary methods that can reduce the time and costs required for antibody design by minimizing failures and increasing the success rate of experimental tests...
April 18, 2024: Drug Discovery Today
https://read.qxmd.com/read/38642406/automated-treatment-planning-for-whole-breast-irradiation-with-individualized-tangential-imrt-fields
#11
JOURNAL ARTICLE
Giulianne Rivelli Rodrigues Zaratim, Ricardo Gomes Dos Reis, Marcos Antônio Dos Santos, Nathalya Ala Yagi, Luis Felipe Oliveira E Silva
PURPOSES: This study aimed to develop and validate algorithms for automating intensity modulated radiation therapy (IMRT) planning in breast cancer patients, with a focus on patient anatomical characteristics. MATERIAL AND METHODS: We retrospectively selected 400 breast cancer patients without lymph node involvement for automated treatment planning. Automation was achieved using the Eclipse Scripting Application Programming Interface (ESAPI) integrated into the Eclipse Treatment Planning System...
April 20, 2024: Journal of Applied Clinical Medical Physics
https://read.qxmd.com/read/38640824/artificial-intelligence-for-breast-cancer-detection-technology-challenges-and-prospects
#12
REVIEW
Oliver Díaz, Alejandro Rodríguez-Ruíz, Ioannis Sechopoulos
PURPOSE: This review provides an overview of the current state of artificial intelligence (AI) technology for automated detection of breast cancer in digital mammography (DM) and digital breast tomosynthesis (DBT). It aims to discuss the technology, available AI systems, and the challenges faced by AI in breast cancer screening. METHODS: The review examines the development of AI technology in breast cancer detection, focusing on deep learning (DL) techniques and their differences from traditional computer-aided detection (CAD) systems...
April 16, 2024: European Journal of Radiology
https://read.qxmd.com/read/38640822/using-deep-learning-to-optimize-the-prostate-mri-protocol-by-assessing-the-diagnostic-efficacy-of-mri-sequences
#13
JOURNAL ARTICLE
Stefan J Fransen, Christian Roest, Quintin Y Van Lohuizen, Joeran S Bosma, Frank F J Simonis, Thomas C Kwee, Derya Yakar, Henkjan Huisman
PURPOSE: To explore diagnostic deep learning for optimizing the prostate MRI protocol by assessing the diagnostic efficacy of MRI sequences. METHOD: This retrospective study included 840 patients with a biparametric prostate MRI scan. The MRI protocol included a T2-weighted image, three DWI sequences (b50, b400, and b800 s/mm2 ), a calculated ADC map, and a calculated b1400 sequence. Two accelerated MRI protocols were simulated, using only two acquired b-values to calculate the ADC and b1400...
April 16, 2024: European Journal of Radiology
https://read.qxmd.com/read/38640741/comparing-preferences-for-skin-cancer-screening-ai-enabled-app-vs-dermatologist
#14
JOURNAL ARTICLE
Susanne Gaube, Isabell Biebl, Magdalena Karin Maria Engelmann, Anne-Kathrin Kleine, Eva Lermer
BACKGROUND AND AIM: Skin cancer is a major public health issue. While self-examinations and professional screenings are recommended, they are rarely performed. Mobile health (mHealth) apps utilising artificial intelligence (AI) for skin cancer screening offer a potential solution to aid self-examinations; however, their uptake is low. Therefore, the aim of this research was to examine provider and user characteristics influencing people's decisions to seek skin cancer screening performed by a mHealth app or a dermatologist...
April 15, 2024: Social Science & Medicine
https://read.qxmd.com/read/38640702/learning-the-cellular-activity-representation-based-on-gene-regulatory-networks-for-prediction-of-tumor-response-to-drugs
#15
JOURNAL ARTICLE
Xinping Xie, Fengting Wang, Guanfu Wang, Weiwei Zhu, Xiaodong Du, Hongqiang Wang
Predicting the response of tumor cells to anti-tumor drugs is critical to realizing cancer precision medicine. Currently, most existing methods ignore the regulatory relationships between genes and thus have unsatisfactory predictive performance. In this paper, we propose to predict anti-tumor drug efficacy via learning the activity representation of tumor cells based on a priori knowledge of gene regulation networks (GRNs). Specifically, the method simulates the cellular biosystem by synthesizing a cell-gene activity network and then infers a new low-dimensional activity representation for tumor cells from the raw high-dimensional expression profile...
April 2, 2024: Artificial Intelligence in Medicine
https://read.qxmd.com/read/38639960/-application-of-artificial-intelligence-in-the-diagnosis-of-prostate-cancer
#16
JOURNAL ARTICLE
Ke-Xin Zhang, Zhan-Peng Yu, Tian-Yi Shen, Hao Tang
With the rise of precision medicine, the continuous expansionWith the rise of precision medicine, the continuous expansion the collective push from many other the application of Artificial Intelligence (AI) in prostate cancer diagnosis is increasingly becoming a focal point. AI technology can effectively utilize diverse detection methods such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and whole pathology slide imaging to efficiently identify and differentiate between benign and malignant lesions...
December 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38637674/predicting-non-muscle-invasive-bladder-cancer-outcomes-using-artificial-intelligence-a-systematic-review-using-appraise-ai
#17
REVIEW
Jethro C C Kwong, Jeremy Wu, Shamir Malik, Adree Khondker, Naveen Gupta, Nicole Bodnariuc, Krishnateja Narayana, Mikail Malik, Theodorus H van der Kwast, Alistair E W Johnson, Alexandre R Zlotta, Girish S Kulkarni
Accurate prediction of recurrence and progression in non-muscle invasive bladder cancer (NMIBC) is essential to inform management and eligibility for clinical trials. Despite substantial interest in developing artificial intelligence (AI) applications in NMIBC, their clinical readiness remains unclear. This systematic review aimed to critically appraise AI studies predicting NMIBC outcomes, and to identify common methodological and reporting pitfalls. MEDLINE, EMBASE, Web of Science, and Scopus were searched from inception to February 5th, 2024 for AI studies predicting NMIBC recurrence or progression...
April 18, 2024: NPJ Digital Medicine
https://read.qxmd.com/read/38637299/use-of-artificial-intelligence-for-the-prediction-of-lymph-node-metastases-in-early-stage-colorectal-cancer-systematic-review
#18
JOURNAL ARTICLE
Nasya Thompson, Arthur Morley-Bunker, Jared McLauchlan, Tamara Glyn, Tim Eglinton
BACKGROUND: Risk evaluation of lymph node metastasis for early-stage (T1 and T2) colorectal cancers is critical for determining therapeutic strategies. Traditional methods of lymph node metastasis prediction have limited accuracy. This systematic review aimed to review the potential of artificial intelligence in predicting lymph node metastasis in early-stage colorectal cancers. METHODS: A comprehensive search was performed of papers that evaluated the potential of artificial intelligence in predicting lymph node metastasis in early-stage colorectal cancers...
March 1, 2024: BJS Open
https://read.qxmd.com/read/38637186/bench-to-bedside-imaging-in-brain-metastases-a-road-to-precision-oncology
#19
REVIEW
S Shukla, A Karbhari, S Rastogi, U Agarwal, P Rai, A Mahajan
Radiology has seen tremendous evolution in the last few decades. At the same time, oncology has made great strides in diagnosing and treating cancer. Distant metastases of neoplasms are being encountered more often in light of longer patient survival due to better therapeutic strategies and diagnostic methods. Brain metastasis (BM) is a dismal manifestation of systemic cancer. In the present scenario, magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography (PET) are playing a big role in providing molecular information about cancer...
March 16, 2024: Clinical Radiology
https://read.qxmd.com/read/38636778/fast-track-development-and-multi-institutional-clinical-validation-of-an-artificial-intelligence-algorithm-for-detection-of-lymph-node-metastasis-in-colorectal-cancer
#20
JOURNAL ARTICLE
Avri Giammanco, Andrey Bychkov, Simon Schallenberg, Tsvetan Tsvetkov, Junya Fukuoka, Alexey Pryalukhin, Fabian Mairinger, Alexander Seper, Wolfgang Hulla, Sebastian Klein, Alexander Quaas, Reinhard Büttner, Yuri Tolkach
Lymph node metastasis (LNM) detection can be automated using artificial intelligence-based diagnostic tools. Only limited studies have addressed this task for colorectal cancer. The aim of this study was to develop of a clinical-grade digital pathology tool for LNM detection in colorectal cancer (CRC) using the original fast-track framework. The training cohort included 432 slides from one department. A segmentation algorithm detecting 8 relevant tissue classes was trained. The test cohorts consisted of materials from five pathology departments digitized by four different scanning systems...
April 16, 2024: Modern Pathology
keyword
keyword
163425
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.